InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Mccluski Stephen C. Officer active across 2 companies, notably MONRO, INC.. Cumulatively, 8 disclosures have been published. Activity tracked since 6 August 2021. The latest transaction was disclosed on 11 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Stephen C. McCluski is a declarant linked to MONRO, INC. and ImmunoGen, Inc., where he is a director. He has 8 filings in total. In the sampled recent filings from 2021-08-10 to 2026-08-12, the modal transaction nature is Attribution, with 0 EUR of buys and 0 EUR of sells.